Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
8.06
+0.40 (5.22%)
At close: Mar 9, 2026, 4:00 PM EDT
8.00
-0.06 (-0.74%)
After-hours: Mar 9, 2026, 7:07 PM EDT
Upstream Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 436 | 881 | - | - |
| Enterprise Value | 65 | 1,043 | - | - |
| Last Close Price | 8.06 | 16.44 | - | - |
| PS Ratio | 155.61 | 371.78 | - | - |
| PB Ratio | 1.15 | 1.88 | - | - |
| P/TBV Ratio | 1.15 | 1.88 | - | - |
| EV/Sales Ratio | 23.06 | 440.20 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0.01 |
| Net Debt / Equity Ratio | -0.98 | -1.00 | -1.02 | -2.54 |
| Net Debt / EBITDA Ratio | 2.64 | 6.03 | 2.74 | 0.71 |
| Net Debt / FCF Ratio | 3.03 | 7.85 | 2.88 | 0.89 |
| Asset Turnover | 0.01 | 0.01 | 0.04 | - |
| Quick Ratio | 31.47 | 43.93 | 16.89 | 3.60 |
| Current Ratio | 32.67 | 44.63 | 17.96 | 3.77 |
| Return on Equity (ROE) | -40.80% | -21.75% | -35.88% | - |
| Return on Assets (ROA) | -28.15% | -16.23% | -36.96% | - |
| Return on Capital Employed (ROCE) | -37.00% | -16.50% | -36.20% | -175.50% |
| Earnings Yield | -31.18% | -7.13% | - | - |
| FCF Yield | -28.14% | -6.77% | - | - |
| Buyback Yield / Dilution | -1624.00% | -363.22% | -5.49% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.